Aging biology was transformed in 2013 when López-Otín et al. published "The Hallmarks of Aging" in Cell — a framework identifying nine (later expanded to twelve) biological processes that drive aging across species. This framework gave researchers a shared vocabulary and a systematic way to study aging: identify a hallmark, find compounds that modulate it, test whether modulation slows or reverses aging parameters.¹

The OSYRIS Longevity category maps directly onto this framework. Each compound targets a specific hallmark — and no two compounds target the same one.

Telomere shortening is the biological clock that limits cell division. Epithalon targets this directly by reportedly reactivating telomerase — the enzyme that extends telomeres. If the data holds, Epithalon addresses what may be the most fundamental aging mechanism: the countdown timer built into every cell.

The tension: Telomere extension could theoretically increase cancer risk (removing the division limit). The counterargument: critically short telomeres cause genomic instability that also promotes cancer. Where the net risk falls is unresolved.

Evidence strength: Consistent findings within Khavinson's laboratory. Limited independent replication. Lifespan extension reported in mouse models.

→ Read the full Epithalon research overview

NAD+ sits at the intersection of two hallmarks. As a sirtuin co-substrate, it regulates gene expression, DNA repair, and mitochondrial function. As a PARP substrate, it's consumed during DNA damage repair. The age-related decline in NAD+ creates a vicious cycle: more DNA damage → more PARP consumption → less NAD+ → less sirtuin activity → worse mitochondrial function → more damage.

The landmark: Gomes et al. 2013 in Cell showed that restoring NAD+ in aged mice reversed mitochondrial dysfunction in muscle to levels comparable to young mice.

Evidence strength: Strong preclinical data from multiple international laboratories. Human trials show NAD+ level increases with precursor supplementation, but clinically meaningful human health outcomes not yet proven.

→ Read the full NAD+ research overview → NAD+ vs NMN comparison

MOTS-C also targets mitochondrial dysfunction but through a completely different mechanism than NAD+. Where NAD+ works inside the mitochondria (electron transport, sirtuin activation), MOTS-C works as a signal sent FROM the mitochondria to the nucleus — a retrograde communication that triggers AMPK-mediated metabolic adaptation.

The discovery: MOTS-C was only identified in 2015. It revealed mitochondria as active signaling organelles, not just power generators. The finding that MOTS-C increases during exercise in humans connected mitochondrial signaling to the most robustly validated anti-aging intervention: physical activity.

Evidence strength: Growing rapidly from the USC laboratory. Independent replication emerging. No human clinical trials.

→ Read the full MOTS-C research overview

B12 targets aging through a less obvious but well-established pathway: one-carbon metabolism and DNA methylation. Methylation is the primary epigenetic modification that regulates gene expression, and methylation patterns change systematically with age — the "epigenetic clock." B12 is a required cofactor in the methylation pathway (methionine synthase → SAM → methylation).

The connection: B12 deficiency disrupts methylation, accelerates homocysteine accumulation, and impairs neural myelin maintenance. B12 levels decline with age due to reduced absorption efficiency.

Evidence strength: Extensive epidemiological and biochemical data. B12's role in one-carbon metabolism is well-established. Direct longevity extension data is limited.

LA-31 represents emerging longevity research targeting broader cellular health pathways. The longevity field is rapidly expanding, and newer compounds are being investigated alongside established ones to identify novel intervention points in the aging network.

The most sophisticated longevity research protocols don't target a single hallmark — they investigate whether addressing multiple hallmarks simultaneously produces effects beyond single-hallmark intervention.

The OSYRIS Longevity category enables this approach:

Combination 1: Epithalon + NAD+ — Telomere maintenance (Epithalon) + sirtuin activation and mitochondrial function (NAD+). Two different hallmarks, two different mechanisms, potentially additive effects.

Combination 2: NAD+ + MOTS-C — Two approaches to mitochondrial dysfunction from different directions: NAD+ works inside mitochondria (electron transport, sirtuins), MOTS-C works as a mitochondrial-to-nuclear signal (AMPK). Same hallmark, complementary mechanisms.

Combination 3: Full category — Telomere maintenance + sirtuin activation + mitochondrial signaling + epigenetic support. Addresses four hallmarks simultaneously.

Whether multi-hallmark intervention produces synergistic, additive, or diminishing effects is one of the most important open questions in aging biology.